Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-01-25
1991-01-29
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, A61K 3726, A61K 3736
Patent
active
049886754
ABSTRACT:
The invention concerns a method for treating and preventing secondary effects of hyperinsulinemia by application of insulin-like growth factor I (IGF I), and pharmaceutical compositions comprising IGF I which are useful for this purpose.
REFERENCES:
Scheiwiller et al., Nature, vol. 323, 11, Sep. 1986, pp. 169-171.
Stedman, Stedman's Medical Dictionary, p. 880, 24th Edition, 1982, Williams & Wilkins.
Guler et al., New England Journal of Medicine, vol. 317, No. 3, pp. 137-140, (1987).
Froesch Ernst R.
Guler Hans-Peter
Schmid Christoph
Zapf Jurgen
Ciba-Geigy Corporation
Fishman Irving M.
Koh Choon
Nowak Henry P.
Schain Howard E.
LandOfFree
Method for preventing secondary effects does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing secondary effects, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing secondary effects will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-813712